Flavonoids: Potential New Drug Candidates for Attenuating Vascular Remodeling in Pulmonary Hypertension
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xiaoyi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Acade…. Hauptthemen laut MEDLINE: Flavonoids, Hypertension, Pulmonary, Vascular Remodeling. Die Arbeit nennt 262 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a progressive and life-threatening disorder characterized by elevated pulmonary arterial pressure, leading to right ventricular remodeling and significant mortality. Pulmonary arterial remodeling, a critical pathological feature of PH, refers to structural alterations in the pulmonary vasculature driven by various pathogenic factors. Targeting this remodeling process has emerged as a promising strategy for treating and potentially curing the disease. In recent years, growing interest has been directed toward exploring natural products as anti-PH agents. Among them, flavonoids have demonstrated potent efficacy in the cardiopulmonary system. As a prominent class of natural small-molecule compounds, flavonoids exhibit broad biological activities, such as antioxidant, anti-inflammatory, and anti-proliferative properties. They have shown the ability to inhibit remodeling and restore vascular function across various vessel types, including pulmonary arteries. This review summarizes the effects of flavonoids on PH, with emphasis on their inhibition of pulmonary arterial remodeling. We also discuss the therapeutic potential of flavonoids in PH and discuss their underlying mechanisms of action. These insights may guide the development of next-generation PH therapeutics, either through the utilization of flavonoid-based structures or the preparation of compound formulations containing flavonoids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 10005…
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- School of Pharmacy, Henan University, Kaifeng 475004, China.
ORCID-Profile: Difei Gong
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Zhang, X., Chen, M., Wang, R., Liu, R., Gong, D., Zhang, M., He, Y., Du, G., Fang, L., & Yuan, T. (2025). Flavonoids: Potential New Drug Candidates for Attenuating Vascular Remodeling in Pulmonary Hypertension. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010210
Vancouver
Zhang X, Chen M, Wang R, Liu R, Gong D, Zhang M, et al. Flavonoids: Potential New Drug Candidates for Attenuating Vascular Remodeling in Pulmonary Hypertension. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010210
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaoyi and Chen, Mingshu and Wang, Ranran and Liu, Ruiqi and Gong, Difei and Zhang, Meng and He, Yangyang and Du, Guanhua and Fang, Lianhua and Yuan, Tianyi},
title = {Flavonoids: Potential New Drug Candidates for Attenuating Vascular Remodeling in Pulmonary Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010210}
}
EUVIMED